Bleeding Pattern and User Satisfaction During Second Consecutive MIRENA® in Contraception and Treatment of Menorrhagia

Inclusion Criteria: * Woman currently using MIRENA for contraception or menorrhagia with duration use between 4 years 3 months and 4 years 9 months and willingness to continue with the method. * Normal size uterus at insertion, corresponding to sound measure of 6-10 cm. * Clinically normal cervical smear result within 12 preceding months or at screening. * Clinically normal breast examination findings. For patients \>/= 40 years at screening, a clinically normal mammography result within 12 preceding months or at screening is required. Exclusion Criteria: * Menopausal symptoms impairing patient's quality of life or current estrogen therapy for menopausal symptoms. * Known or suspected pregnancy. * Any distortion of the uterine cavity, including congenital or acquired uterine anomalies and fibroids distorting the uterine cavity. * Current or recurrent pelvic inflammatory disease. * Abnormal uterine bleeding of unknown origin. * Acute cervicitis or vaginitis not responding to treatment. * History of, diagnosed or suspected genital or other malignancy (excluding treated squamous cell carcinoma of the skin), and untreated cervical dysplasia. * Any active acute liver disease or liver tumor.